Cargando…

Implantable Defibrillators for Secondary Prevention of Sudden Cardiac Death in Cardiac Surgery Patients With Perioperative Ventricular Arrhythmias

BACKGROUND: Randomized studies of implantable cardioverter defibrillators (ICD) have excluded sudden cardiac death survivors who had revascularization before or after an arrhythmic event. To evaluate the role of ICD and the effects of clinical variables including degree of revascularization, we stud...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nageh, Maged F., Kim, John J., Chen, Lie‐Hong, Yao, Janis F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4310357/ https://www.ncbi.nlm.nih.gov/pubmed/25146702 http://dx.doi.org/10.1161/JAHA.113.000686

Ejemplares similares

Appropriate Implantable Cardioverter-Defibrillator Therapy in Patients with Ventricular Arrhythmia of Unclear Cause in Secondary Prevention of Sudden Cardiac Death
por: Noordman, Alwin B. P., et al.
Publicado: (2023)

Subcutaneous implantable cardioverter-defibrillator (S-ICD) for secondary prevention of sudden cardiac death
por: Kempa, Maciej, et al.
Publicado: (2016)

Implantable Cardioverter‐Defibrillators for Secondary Prevention of Sudden Cardiac Death: A Review
por: Borne, Ryan T., et al.
Publicado: (2017)

Ventricular tachycardia prediction in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death
por: Lebedeva, Viktoria K., et al.
Publicado: (2018)

Use of Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death in Asia
por: Ueda, Nobuhiko, et al.
Publicado: (2023)

The Use of Implantable Cardioverter-defibrillators in the Prevention of Sudden Cardiac Death: A Focus on Congenital Heart Disease and Inherited Arrhythmia Syndromes
por: Goldstein, Sarah A., et al.
Publicado: (2018)

Defibrillators for prevention from sudden cardiac death: is it that easy?
por: Duncker, David, et al.
Publicado: (2020)

Efficacy of Implantable Cardioverter-defibrillators for Secondary Prevention of Sudden Cardiac Death in Patients with End-stage Renal Disease
por: Payne, Taylor, et al.
Publicado: (2020)

Incidence of Sudden Cardiac Death and Life-Threatening Arrhythmias in Clinically Manifest Cardiac Sarcoidosis With and Without Current Indications for an Implantable Cardioverter Defibrillator
por: Nordenswan, Hanna-Kaisa, et al.
Publicado: (2022)

Advanced imaging for risk stratification for ventricular arrhythmias and sudden cardiac death
por: Xie, Eric, et al.
Publicado: (2022)

Predictors of appropriate therapy in patients with implantable cardioverter-defibrillator for primary prevention of sudden cardiac death
por: Ahmed, Imdad, et al.
Publicado: (2010)

Subcutaneous Implantable Cardioverter Defibrillators for the Prevention of Sudden Cardiac Death: Pediatric Single-Center Experience
por: Wieniawski, Piotr, et al.
Publicado: (2022)

Secondary prevention of sudden cardiac death
por: Chatterjee, Neal A., et al.
Publicado: (2020)

Comment on the ESC Guidelines 2022 for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
por: Cuervo, David Calvo
Publicado: (2023)

Underutilization of Implantable Cardioverter Defibrillator in Primary Prevention of Sudden Cardiac Arrest
por: Lakshmanadoss, Umashankar, et al.
Publicado: (2011)

Ryanodine receptor-mediated arrhythmias and sudden cardiac death
por: Blayney, Lynda M., et al.
Publicado: (2009)

Preventing Sudden Death And The Use Of Prophylactic Implanted Defibrillators
por: Ray, Indranill Basu
Publicado: (2003)

Classic and Novel Biomarkers as Potential Predictors of Ventricular Arrhythmias and Sudden Cardiac Death
por: Shomanova, Zornitsa, et al.
Publicado: (2020)

Ventricular arrhythmia and sudden cardiac death in hypertrophic cardiomyopathy: From bench to bedside
por: Shen, Hua, et al.
Publicado: (2022)

Effects and Complications of Subcutaneous Implantable Cardioverter-Defibrillator in the Prevention of Sudden Cardiac Death: A Narrative Review
por: Pagore, Prasad A, et al.
Publicado: (2022)

Transgenic models of cardiac arrhythmias and sudden death
por: Remme, Carol Ann
Publicado: (2013)

Editorial: The role of sex in cardiac arrhythmias and sudden cardiac death
por: Pollevick, Matias E., et al.
Publicado: (2023)

Prevention of sudden cardiac death by the wearable cardioverter defibrillator in a young patient with cardiac sarcoidosis
por: Andrié, René, et al.
Publicado: (2017)

Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF
por: Curtain, James P, et al.
Publicado: (2021)

Wearable Cardioverter-defibrillators for the Prevention of Sudden Cardiac Death: A Meta-analysis
por: Nguyen, Elaine, et al.
Publicado: (2018)

Sudden Cardiac Death Risk over Time in HCM Patients with Implantable Cardioverter-Defibrillator
por: Klopotowski, Mariusz, et al.
Publicado: (2022)

Prospective Observational Study of Implantable Cardioverter‐Defibrillators in Primary Prevention of Sudden Cardiac Death: Study Design and Cohort Description
por: Cheng, Alan, et al.
Publicado: (2013)

Cardiac defibrillator implantation in patients with syncope and inducible ventricular arrhythmia: insights from the German DEVICE registry
por: Kahle, A K, et al.
Publicado: (2023)

Single‐ Versus Dual‐Chamber Implantable Cardioverter‐Defibrillator for Primary Prevention of Sudden Cardiac Death in the United States
por: Margolis, Gilad, et al.
Publicado: (2023)

Ventricular Arrhythmia Discriminator Programming and the Impact on the Incidence of Inappropriate Therapy in Patients with Implantable Cardiac Defibrillators
por: Srivatsa, Uma N, et al.
Publicado: (2007)

Development and external validation of prediction models to predict implantable cardioverter-defibrillator efficacy in primary prevention of sudden cardiac death
por: Verstraelen, Tom E, et al.
Publicado: (2021)

Management of sudden cardiac death in cardiac sarcoidosis using the wearable cardioverter defibrillator
por: Skowasch, Dirk, et al.
Publicado: (2018)

Arrhythmias and sudden cardiac death in the COVID-19 pandemic
por: Kuck, Karl-Heinz
Publicado: (2020)

Inherited arrhythmia syndrome predisposing to sudden cardiac death
por: Kim, Yun Gi, et al.
Publicado: (2021)

Sympathetic Activation in Hypertensive Chronic Kidney Disease – A Stimulus for Cardiac Arrhythmias and Sudden Cardiac Death?
por: Kiuchi, Márcio Galindo, et al.
Publicado: (2020)

Sex, Rhythm & Death: The effect of sexual activity on cardiac arrhythmias and sudden cardiac death
por: Dye, Cicely Anne, et al.
Publicado: (2022)

Ventricular tachycardia as presenting arrhythmia as a determinant of appropriate implantable cardioverter-defibrillator therapy in secondary prevention
por: Noordman, A B P, et al.
Publicado: (2023)

Updated risk assessments for sudden cardiac death in hypertrophic cardiomyopathy patients with implantable cardioverter-defibrillator
por: Park, Yae Min
Publicado: (2023)

Cardiac defibrillator implantation in patients with syncope and inducible ventricular arrhythmia: insights from the German Device Registry
por: Kahle, Ann-Kathrin, et al.
Publicado: (2023)

Impact of Cardiac Magnetic Resonance (CMR) on utilization of Implantable-Cardioverter-Defibrillators (ICD) for primary prophylaxis of sudden cardiac death
por: Ertel, Andrew, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_vb3r6brqor3iq4c6uuh5eofdka